Struggling with treatment-resistant Bartonella Infection?
Find hope through our groundbreaking clinical trial at The Biologix Center for Optimum Health.
About the Study:
Supported by IRB, our clinical trial aims to consistently replicate our early promising results. Dive into our research on the virome and its role in maintaining human health.
Treatment Details:
Participate in comprehensive treatments and supportive therapies daily (Monday to Friday). Learn what to expect during your program of care.
Embark on a one-to-two-week program of care, coupled with virtual follow-up appointments for continuous monitoring.
Benefit from personalized treatment with induced native phage therapy, offering a safe and non-allergenic alternative.
Goal:
Our primary aim is to combat treatment-resistant Bartonella Infection, leading to symptom relief and improved quality of life.
Prerequisites:
Recent laboratory test results demonstrating positive for one or more types of Bartonella and a commitment to retesting post-treatment.